These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 16827890)

  • 21. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
    Exp Dermatol; 2006 Aug; 15(8):582-8. PubMed ID: 16842596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice.
    Yamashita H; Makino T; Mizukami H; Nose M
    Eur J Pharmacol; 2007 Jun; 563(1-3):233-9. PubMed ID: 17336291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice.
    Yatsuzuka R; Inoue T; Jiang S; Nakano Y; Kamei C
    Eur J Pharmacol; 2007 Jun; 565(1-3):225-31. PubMed ID: 17459367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
    Nakashima C; Otsuka A; Kabashima K
    Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice.
    Takaoka A; Arai I; Sugimoto M; Futaki N; Sakurai T; Honma Y; Nakaike S
    Exp Dermatol; 2007 Apr; 16(4):331-9. PubMed ID: 17359340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
    Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
    J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for preclinical assessment of antipruritic agents and itch mechanisms independent of mast-cell histamine.
    Kuraishi Y
    Biol Pharm Bull; 2015; 38(5):635-44. PubMed ID: 25947907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate-type allergic and protease-mediated reactions are involved in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice.
    Yamada Y; Ueda Y; Nakamura A; Kanayama S; Tamura R; Hashimoto K; Matsumoto T; Ishii R
    Exp Dermatol; 2018 Apr; 27(4):418-426. PubMed ID: 28191683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
    Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
    Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study.
    Ohsawa Y; Hirasawa N
    Allergol Int; 2014 Dec; 63(4):533-42. PubMed ID: 25249063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of α-Melanocyte-Stimulating Hormone-Thromboxane A
    Andoh T; Akasaka C; Shimizu K; Lee JB; Yoshihisa Y; Shimizu T
    Am J Pathol; 2019 Sep; 189(9):1775-1785. PubMed ID: 31220451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
    Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
    Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
    Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
    Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
    Andoh T; Kuraishi Y
    J Dermatol Sci; 2014 Dec; 76(3):206-13. PubMed ID: 25458869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atopic dermatitis-like skin lesions with IgE hyperproduction and pruritus in KFRS4/Kyo rats.
    Kuramoto T; Yokoe M; Tanaka D; Yuri A; Nishitani A; Higuchi Y; Yoshimi K; Tanaka M; Kuwamura M; Hiai H; Kabashima K; Serikawa T
    J Dermatol Sci; 2015 Nov; 80(2):116-23. PubMed ID: 26454563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
    Exp Dermatol; 2005 Dec; 14(12):898-905. PubMed ID: 16274457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1.
    Groneberg DA; Serowka F; Peckenschneider N; Artuc M; Grützkau A; Fischer A; Henz BM; Welker P
    J Neuroimmunol; 2005 Apr; 161(1-2):87-92. PubMed ID: 15748947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyozellin alleviates atopic dermatitis-like inflammatory and pruritic responses in activated keratinocytes and mast cells.
    Jeong NH; Lee S; Choi JK; Choi YA; Kim MJ; Lee HS; Shin TY; Jang YH; Song KS; Kim SH
    Biomed Pharmacother; 2020 Feb; 122():109743. PubMed ID: 31918284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of fexofenadine on pruritus in a mouse model (HR-ADf) of atopic dermatitis.
    Akamatsu H; Makiura M; Yamamoto N; Yagami A; Shimizu Y; Matsunaga K
    J Int Med Res; 2006; 34(5):495-504. PubMed ID: 17133778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.
    Yoshioka T; Imura K; Hikita I; Hirasawa T; Sakata T; Matsutani T; Horikawa T; Arimura A
    Immunology; 2007 May; 121(1):51-61. PubMed ID: 17313488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.